Abstract
Osteoporosis (thin bones) is a disease caused by loss of bone mass and microarchitectural deterioration of the skeleton, leading to enhanced bone fragility and increased risk for fractures with minimal or no trauma at all. Conventionally, the disease is diagnosed when the bone mineral density is 2.5 standard deviations below the young adult mean. A bone mineral density between 1 and 2.5 standard deviations below the young adult mean is termed “osteopenia.” Osteoporosis is the most common disease of the musculoskeletal system. Fifty-four percent of postmenopausal women in the United States have osteopenia and another 30% have osteoporosis. Up to 20% of patients with osteoporosis die after hip fractures and 40% can no longer live independently. Although not a rheumatic disorder, osteoporosis is of major interest to rheumatologists, as the arthritic processes that affect the cartilage surfaces and the synovial lining may also involve the subchondral bone and the joint capsule. Moreover, rheumatic diseases such as osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, and the spondyloarthropathies may involve not only skeletal tissues at juxtaarticular and subchondral sites but also produce generalized effects on bone remodeling that affect the entire skeleton.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Manolagas, S. C. and Jilka, R. L. (1995) Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332, 305–311.
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D., Abrams, J., et al. (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257, 88–91.
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., and Boyce, B. F. (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-ß. Nature Med. 2, 1132–1136.
Girasole, G., Jilka, R. L., Passeri, G., Boswell, H. S., Boder, G., Williams, D. C., et al. (1992) 17ß-Estradiol inhibits Interleukin-6 production by murine bone marrow stromal cells and human osteoblasts in-vitro: a potential mechanism for the antiosteoporotic effects of estrogens. J. Clin. Invest. 89, 883–891.
Pottratz, S., Bellido, T., Mocharla, H., Crabb, D., and Manolagas, S. C. (1994) 17ß-Estradiol inhibits transcription from the human interleukin-6 promoter. J. Clin. Invest. 93, 944–950.
Bellido, T., Jilka, R. L., Boyce, B., Girasole, G., Broxmeyer, H., Dalrymple, S. A., et al. (1995) Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: the role of the androgen receptor. J. Clin. Invest. 95, 2886–2895.
Lin, S.-C., Yamate, T., Taguchi, Y., Borba, V. Z. C., Girasole, G., O’Brien, C. A., et al. (1997) Regulation of the gp80 and gp 130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J. Clin. Invest. 100, 1980–1990.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, A., Tanaka, H., et al. (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189–1196.
Jilka, R. L., Takahashi, K., Munshi, M., Williams, D. C., Roberson, P. K., Parfitt, A. M., et al. (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: evidence for autonomy from factors released during bone resorption. J. Clin. Invest. 101, 1942–1950.
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1997) The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology 138, 4013–4021.
Pacifici, R. (1998) Cytokines, estrogen, and postmenopausal osteoporosis: the second decade. Endocrinology 139, 2659–2661.
Sunyer, T., Lewis, J., Collin-Osdoby, P., and Osdoby, P. (1999) Estrogen’s bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J. Clin. Invest. 103, 1409–1418.
Manolagas, S. C., Weinstein, R. S., Bellido, T., and Bodenner, D. L. Opposite effects of estrogen on the life span of osteoblasts/osteocytes versus osteoclasts in vivo and in vitro: an explanation of the imbalance between formation and resorption in estrogen deficiency. J. Bone Miner. Res. (abstract), in press.
Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., and Manolagas, S. C. (1996) Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97, 1732–1740.
Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S. P., Takahashi, K., Parfitt, A. M., et al. (1997) Increase adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J. Bone Miner. Res. 12, 1772–1779.
Lecka-Cznernik, B., Gubrij, I., Moerman, E. A., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., et al. (1999) Inhibition of Osf2/Cbfal expression and terminal osteoblast differentiation by PPAR-gamma 2. J. Cell. Biochem. 74, 357–371.
Frost, H. M. (1960) In vivo osteocyte death. J. Bone Joint Surg. [Am.] 42, 138–143.
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274–282.
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., and Manolagas, S. C. (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest., 104, 439–446.
Lane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., and Arnaud, C. D. (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. J. Clin. Invest. 102, 1627–1633.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Manolagas, S.C. (2000). Osteoporosis. In: Tsokos, G.C. (eds) Principles of Molecular Rheumatology. Current Molecular Medicine, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-018-6_26
Download citation
DOI: https://doi.org/10.1007/978-1-59259-018-6_26
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-182-0
Online ISBN: 978-1-59259-018-6
eBook Packages: Springer Book Archive